Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over
Hims & Hers Health stock price nears record high on news that it will offer GLP-1 weight-loss drugs amid shortages
Hims & Hers is launching a weight loss program for its digital health portfolio
Hims just went public. What does that mean for the future of healthcare?
The Hims of sleep? DTC brand reimagines snooze supplements
Hims launches Hers: Men’s wellness startup now has a “badass sister”